# Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

> **NCT06191133** · PHASE1 · RECRUITING · sponsor: **Lindsay Ferguson, MD** · enrollment: 24 (estimated)

## Conditions studied

- Cervical Intraepithelial Neoplasia
- Invasive Cervical Cancer

## Interventions

- **DRUG:** Fenofibrate
- **PROCEDURE:** Cervical Conization
- **PROCEDURE:** Hysterectomy
- **RADIATION:** Chemoradiation

## Key facts

- **NCT ID:** NCT06191133
- **Lead sponsor:** Lindsay Ferguson, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-20
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06191133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06191133, "Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06191133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
